%0 Journal Article
%T Ionic liquid-based formulation approaches for enhanced transmucosal drug delivery.
%A Khan O
%A Bhawale R
%A Vasave R
%A Mehra NK
%J Drug Discov Today
%V 29
%N 9
%D 2024 Sep 19
%M 39032809
%F 8.369
%R 10.1016/j.drudis.2024.104109
%X The utilization of ionic liquids (ILs) in pharmaceutical drug delivery applications has seen significant expansion in recent years, owing to their distinctive characteristics and inherent adjustability. These innovative compounds can be used to tackle challenges associated with traditional dosage forms, such as polymorphism, inadequate solubility, permeability, and efficacy in topical drug delivery systems. Here, we provide a brief classification of ILs, and their effectiveness in augmenting transmucosal drug delivery approaches by improving the solubility and permeability of active pharmaceutical ingredients (APIs) by temporary mucus modulation aiding the paracellular transport of APIs, prolonging drug retention, and, thus, aiding controlled drug release across various mucosal surfaces. We also highlight potential advances in, and future perspectives of, IL-based formulations in mucosal drug delivery.